- 3.4Impact Factor
- 9.9CiteScore
- 19 daysTime to First Decision
Vaccines, Volume 13, Issue 12
2025 December - 82 articles
Cover Story: This review outlines a coherent framework for the design of the next generation of mRNA cancer vaccines. We examine how modifications spanning nucleosides, UTRs, poly(A) tails, codon usage, and linker sequences—together with lipid nanoparticle formulation—collectively shape protein expression, innate immune sensing, and antigen presentation. By linking these molecular design choices to corse principles of tumor immunology, we show how translation efficiency, immune activation, and antigen presentation can be systematically used. When integrated with advances in neoantigen prediction and immune monitoring, these insights provide a blueprint for the development of next-generation mRNA-based cancer therapies. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.

